STOCK TITAN

[Form 4] First United Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Ardelyx (ARDX) has filed an 8-K detailing three material events.

Item 2.02 – Results of Operations: Q2-25 financial results were released separately as Exhibit 99.1; the filing itself contains no revenue, EPS or guidance figures.

Item 5.02 – Executive Transition: CFO/COO Justin Renz will leave the role on the earlier of 31 Dec 2025 or 30 days after a new CFO begins. Under an August 1, 2025 Transition Agreement he will (i) remain on current salary, benefits and 2025 bonus eligibility (individual component fixed at 100%) through the separation date and (ii) receive change-in-control severance and a 12-month post-separation option exercise window, subject to customary release and compliance conditions.

Item 5.03 – Governance Changes: The Board adopted Second Amended & Restated Bylaws effective August 1. Key revisions tighten shareholder proposal procedures (record-holder requirement, 67% solicitation threshold, nominee cap), update quorum language, drop physical shareholder-list production, introduce a forum-selection clause and make other technical edits.

No other business, transactions or financial statements were reported.

Ardelyx (ARDX) ha presentato un modulo 8-K che dettaglia tre eventi rilevanti.

Voce 2.02 – Risultati Operativi: I risultati finanziari del secondo trimestre 2025 sono stati pubblicati separatamente come Allegato 99.1; il documento stesso non contiene dati su ricavi, utile per azione o previsioni.

Voce 5.02 – Transizione Dirigenziale: Il CFO/COO Justin Renz lascerà il ruolo il prima possibile tra il 31 dicembre 2025 o 30 giorni dopo l’insediamento di un nuovo CFO. Secondo un Accordo di Transizione datato 1 agosto 2025, manterrà (i) lo stipendio attuale, i benefici e l’ammissibilità al bonus 2025 (componente individuale fissata al 100%) fino alla data di separazione e (ii) riceverà un’indennità per cambio di controllo e una finestra di 12 mesi post-separazione per l’esercizio delle opzioni, soggetta a condizioni consuete di rilascio e conformità.

Voce 5.03 – Modifiche alla Governance: Il Consiglio ha adottato il Secondo Statuto Modificato e Ristabilito con effetto dal 1 agosto. Le principali revisioni riguardano l’inasprimento delle procedure per le proposte degli azionisti (requisito di detenzione, soglia di sollecitazione al 67%, limite ai candidati), aggiornamento del quorum, eliminazione della produzione fisica delle liste azionisti, introduzione di una clausola di selezione del foro e altre modifiche tecniche.

Non sono state riportate altre attività, transazioni o bilanci.

Ardelyx (ARDX) ha presentado un formulario 8-K que detalla tres eventos materiales.

Artículo 2.02 – Resultados Operativos: Los resultados financieros del segundo trimestre de 2025 se publicaron por separado como Anexo 99.1; el documento en sí no incluye cifras de ingresos, ganancias por acción ni previsiones.

Artículo 5.02 – Transición Ejecutiva: El CFO/COO Justin Renz dejará el cargo a más tardar el 31 de diciembre de 2025 o 30 días después de que comience un nuevo CFO. Según un Acuerdo de Transición fechado el 1 de agosto de 2025, (i) mantendrá su salario actual, beneficios y elegibilidad para el bono de 2025 (componente individual fijado al 100%) hasta la fecha de separación y (ii) recibirá indemnización por cambio de control y un período de 12 meses después de la separación para ejercer opciones, sujeto a condiciones habituales de liberación y cumplimiento.

Artículo 5.03 – Cambios en la Gobernanza: La Junta adoptó los Estatutos Modificados y Reformulados en segunda instancia, vigentes desde el 1 de agosto. Las revisiones clave ajustan los procedimientos para propuestas de accionistas (requisito de titularidad, umbral de solicitud del 67%, límite de nominados), actualizan el lenguaje del quórum, eliminan la producción física de la lista de accionistas, introducen una cláusula de selección de foro y realizan otras correcciones técnicas.

No se reportaron otros negocios, transacciones ni estados financieros.

Ardelyx(ARDX)는 세 가지 중요한 사건을 상세히 설명하는 8-K 보고서를 제출했습니다.

항목 2.02 – 영업 실적: 2025년 2분기 재무 결과는 별도로 부속서 99.1로 발표되었으며, 본 보고서에는 매출, 주당순이익 또는 전망 수치가 포함되어 있지 않습니다.

항목 5.02 – 임원 교체: CFO/COO 저스틴 렌즈는 새 CFO가 임명된 후 30일 이내 또는 2025년 12월 31일 중 빠른 시점에 직무를 떠납니다. 2025년 8월 1일 체결된 전환 계약에 따라 (i) 분리일까지 현재 급여, 복리후생 및 2025년 보너스 자격(개별 구성 요소 100% 확정)을 유지하며, (ii) 통상적인 해제 및 준수 조건에 따라 경영권 변경 퇴직금과 분리 후 12개월간 주식매수선택권 행사 기간을 받게 됩니다.

항목 5.03 – 거버넌스 변경: 이사회는 8월 1일부터 발효되는 두 번째 수정 및 재작성된 내규를 채택했습니다. 주요 개정 사항은 주주 제안 절차 강화(기록 보유자 요건, 67% 청원 기준, 후보자 제한), 정족수 문구 업데이트, 물리적 주주 명부 제공 중단, 포럼 선택 조항 도입 및 기타 기술적 수정을 포함합니다.

기타 사업, 거래 또는 재무제표는 보고되지 않았습니다.

Ardelyx (ARDX) a déposé un formulaire 8-K détaillant trois événements importants.

Point 2.02 – Résultats d'exploitation : Les résultats financiers du deuxième trimestre 2025 ont été publiés séparément en tant qu’Exhibit 99.1 ; le dépôt lui-même ne contient pas de chiffres concernant les revenus, le BPA ou les prévisions.

Point 5.02 – Transition exécutive : Le CFO/COO Justin Renz quittera son poste au plus tard le 31 décembre 2025 ou 30 jours après la prise de fonction d’un nouveau CFO. Conformément à un accord de transition daté du 1er août 2025, il (i) conservera son salaire actuel, ses avantages et son éligibilité au bonus 2025 (composante individuelle fixée à 100 %) jusqu’à la date de séparation et (ii) bénéficiera d’une indemnité de changement de contrôle ainsi que d’une période de 12 mois après séparation pour exercer ses options, sous réserve des conditions habituelles de renonciation et de conformité.

Point 5.03 – Modifications de la gouvernance : Le Conseil d’administration a adopté les statuts modifiés et révisés pour la seconde fois, effectifs au 1er août. Les principales révisions renforcent les procédures relatives aux propositions des actionnaires (exigence de détenteur, seuil de sollicitation à 67 %, limite de candidats), mettent à jour le quorum, suppriment la production physique de la liste des actionnaires, introduisent une clause de choix de juridiction et apportent d’autres corrections techniques.

Aucune autre activité, transaction ou états financiers n’a été rapportée.

Ardelyx (ARDX) hat ein 8-K Formular eingereicht, das drei wesentliche Ereignisse beschreibt.

Punkt 2.02 – Betriebsergebnisse: Die Finanzergebnisse für das zweite Quartal 2025 wurden separat als Anlage 99.1 veröffentlicht; die Einreichung selbst enthält keine Angaben zu Umsatz, Gewinn pro Aktie oder Prognosen.

Punkt 5.02 – Führungswechsel: CFO/COO Justin Renz wird die Position spätestens am 31. Dezember 2025 oder 30 Tage nach dem Amtsantritt eines neuen CFO verlassen. Gemäß einer Übergangsvereinbarung vom 1. August 2025 wird er (i) bis zum Trennungstermin sein aktuelles Gehalt, Leistungen und die Bonusberechtigung für 2025 (individueller Anteil fest auf 100%) behalten und (ii) eine Abfindung bei Kontrollwechsel sowie ein 12-monatiges Optionsausübungsfenster nach der Trennung erhalten, vorbehaltlich üblicher Freigabe- und Einhaltungsbedingungen.

Punkt 5.03 – Änderungen in der Unternehmensführung: Der Vorstand hat die zweitüberarbeiteten und neu gefassten Satzungen mit Wirkung zum 1. August angenommen. Wichtige Änderungen verschärfen die Verfahren für Aktionärsvorschläge (Eigentumsnachweis, 67% Aufforderungsschwelle, Nominierungslimit), aktualisieren die Quorum-Formulierungen, streichen die physische Erstellung von Aktionärslisten, führen eine Gerichtsstandsklausel ein und nehmen weitere technische Anpassungen vor.

Es wurden keine weiteren Geschäfte, Transaktionen oder Finanzberichte gemeldet.

Positive
  • Orderly CFO transition with up to five-month overlap reduces leadership risk.
  • Extended option exercise window may foster executive alignment through the transition.
  • Bylaw revisions clarify procedural rules, potentially reducing legal ambiguity and costs.
Negative
  • CFO/COO departure introduces leadership uncertainty if successor search drags.
  • Stricter shareholder nomination thresholds could be viewed as entrenchment and attract governance criticism.
  • Lack of embedded Q2 financial data limits immediate assessment of operating performance.

Insights

TL;DR: Bylaw overhaul centralises control; may curb activist leverage but adds procedural clarity.

The revised bylaws impose stricter eligibility and solicitation thresholds on shareholders, reducing the ease of running dissident slates. Adding a forum-selection clause limits venue shopping for litigation, which can lower legal costs but may deter claims. Removing physical shareholder-list requirements aligns with recent Delaware reforms and digital practice. Overall governance impact is mildly shareholder-unfriendly yet operationally efficient.

TL;DR: Planned CFO exit is orderly; financial impact minimal unless replacement lags.

Renz’s staged departure gives up to five months for a successor search, limiting disruption. Continued salary and bonus accrual plus extended option life are modest, one-time costs. Without Q2 metrics we cannot gauge operating performance; investors should review Exhibit 99.1. Overall, today’s disclosures are governance-centric and unlikely to alter near-term valuation.

Ardelyx (ARDX) ha presentato un modulo 8-K che dettaglia tre eventi rilevanti.

Voce 2.02 – Risultati Operativi: I risultati finanziari del secondo trimestre 2025 sono stati pubblicati separatamente come Allegato 99.1; il documento stesso non contiene dati su ricavi, utile per azione o previsioni.

Voce 5.02 – Transizione Dirigenziale: Il CFO/COO Justin Renz lascerà il ruolo il prima possibile tra il 31 dicembre 2025 o 30 giorni dopo l’insediamento di un nuovo CFO. Secondo un Accordo di Transizione datato 1 agosto 2025, manterrà (i) lo stipendio attuale, i benefici e l’ammissibilità al bonus 2025 (componente individuale fissata al 100%) fino alla data di separazione e (ii) riceverà un’indennità per cambio di controllo e una finestra di 12 mesi post-separazione per l’esercizio delle opzioni, soggetta a condizioni consuete di rilascio e conformità.

Voce 5.03 – Modifiche alla Governance: Il Consiglio ha adottato il Secondo Statuto Modificato e Ristabilito con effetto dal 1 agosto. Le principali revisioni riguardano l’inasprimento delle procedure per le proposte degli azionisti (requisito di detenzione, soglia di sollecitazione al 67%, limite ai candidati), aggiornamento del quorum, eliminazione della produzione fisica delle liste azionisti, introduzione di una clausola di selezione del foro e altre modifiche tecniche.

Non sono state riportate altre attività, transazioni o bilanci.

Ardelyx (ARDX) ha presentado un formulario 8-K que detalla tres eventos materiales.

Artículo 2.02 – Resultados Operativos: Los resultados financieros del segundo trimestre de 2025 se publicaron por separado como Anexo 99.1; el documento en sí no incluye cifras de ingresos, ganancias por acción ni previsiones.

Artículo 5.02 – Transición Ejecutiva: El CFO/COO Justin Renz dejará el cargo a más tardar el 31 de diciembre de 2025 o 30 días después de que comience un nuevo CFO. Según un Acuerdo de Transición fechado el 1 de agosto de 2025, (i) mantendrá su salario actual, beneficios y elegibilidad para el bono de 2025 (componente individual fijado al 100%) hasta la fecha de separación y (ii) recibirá indemnización por cambio de control y un período de 12 meses después de la separación para ejercer opciones, sujeto a condiciones habituales de liberación y cumplimiento.

Artículo 5.03 – Cambios en la Gobernanza: La Junta adoptó los Estatutos Modificados y Reformulados en segunda instancia, vigentes desde el 1 de agosto. Las revisiones clave ajustan los procedimientos para propuestas de accionistas (requisito de titularidad, umbral de solicitud del 67%, límite de nominados), actualizan el lenguaje del quórum, eliminan la producción física de la lista de accionistas, introducen una cláusula de selección de foro y realizan otras correcciones técnicas.

No se reportaron otros negocios, transacciones ni estados financieros.

Ardelyx(ARDX)는 세 가지 중요한 사건을 상세히 설명하는 8-K 보고서를 제출했습니다.

항목 2.02 – 영업 실적: 2025년 2분기 재무 결과는 별도로 부속서 99.1로 발표되었으며, 본 보고서에는 매출, 주당순이익 또는 전망 수치가 포함되어 있지 않습니다.

항목 5.02 – 임원 교체: CFO/COO 저스틴 렌즈는 새 CFO가 임명된 후 30일 이내 또는 2025년 12월 31일 중 빠른 시점에 직무를 떠납니다. 2025년 8월 1일 체결된 전환 계약에 따라 (i) 분리일까지 현재 급여, 복리후생 및 2025년 보너스 자격(개별 구성 요소 100% 확정)을 유지하며, (ii) 통상적인 해제 및 준수 조건에 따라 경영권 변경 퇴직금과 분리 후 12개월간 주식매수선택권 행사 기간을 받게 됩니다.

항목 5.03 – 거버넌스 변경: 이사회는 8월 1일부터 발효되는 두 번째 수정 및 재작성된 내규를 채택했습니다. 주요 개정 사항은 주주 제안 절차 강화(기록 보유자 요건, 67% 청원 기준, 후보자 제한), 정족수 문구 업데이트, 물리적 주주 명부 제공 중단, 포럼 선택 조항 도입 및 기타 기술적 수정을 포함합니다.

기타 사업, 거래 또는 재무제표는 보고되지 않았습니다.

Ardelyx (ARDX) a déposé un formulaire 8-K détaillant trois événements importants.

Point 2.02 – Résultats d'exploitation : Les résultats financiers du deuxième trimestre 2025 ont été publiés séparément en tant qu’Exhibit 99.1 ; le dépôt lui-même ne contient pas de chiffres concernant les revenus, le BPA ou les prévisions.

Point 5.02 – Transition exécutive : Le CFO/COO Justin Renz quittera son poste au plus tard le 31 décembre 2025 ou 30 jours après la prise de fonction d’un nouveau CFO. Conformément à un accord de transition daté du 1er août 2025, il (i) conservera son salaire actuel, ses avantages et son éligibilité au bonus 2025 (composante individuelle fixée à 100 %) jusqu’à la date de séparation et (ii) bénéficiera d’une indemnité de changement de contrôle ainsi que d’une période de 12 mois après séparation pour exercer ses options, sous réserve des conditions habituelles de renonciation et de conformité.

Point 5.03 – Modifications de la gouvernance : Le Conseil d’administration a adopté les statuts modifiés et révisés pour la seconde fois, effectifs au 1er août. Les principales révisions renforcent les procédures relatives aux propositions des actionnaires (exigence de détenteur, seuil de sollicitation à 67 %, limite de candidats), mettent à jour le quorum, suppriment la production physique de la liste des actionnaires, introduisent une clause de choix de juridiction et apportent d’autres corrections techniques.

Aucune autre activité, transaction ou états financiers n’a été rapportée.

Ardelyx (ARDX) hat ein 8-K Formular eingereicht, das drei wesentliche Ereignisse beschreibt.

Punkt 2.02 – Betriebsergebnisse: Die Finanzergebnisse für das zweite Quartal 2025 wurden separat als Anlage 99.1 veröffentlicht; die Einreichung selbst enthält keine Angaben zu Umsatz, Gewinn pro Aktie oder Prognosen.

Punkt 5.02 – Führungswechsel: CFO/COO Justin Renz wird die Position spätestens am 31. Dezember 2025 oder 30 Tage nach dem Amtsantritt eines neuen CFO verlassen. Gemäß einer Übergangsvereinbarung vom 1. August 2025 wird er (i) bis zum Trennungstermin sein aktuelles Gehalt, Leistungen und die Bonusberechtigung für 2025 (individueller Anteil fest auf 100%) behalten und (ii) eine Abfindung bei Kontrollwechsel sowie ein 12-monatiges Optionsausübungsfenster nach der Trennung erhalten, vorbehaltlich üblicher Freigabe- und Einhaltungsbedingungen.

Punkt 5.03 – Änderungen in der Unternehmensführung: Der Vorstand hat die zweitüberarbeiteten und neu gefassten Satzungen mit Wirkung zum 1. August angenommen. Wichtige Änderungen verschärfen die Verfahren für Aktionärsvorschläge (Eigentumsnachweis, 67% Aufforderungsschwelle, Nominierungslimit), aktualisieren die Quorum-Formulierungen, streichen die physische Erstellung von Aktionärslisten, führen eine Gerichtsstandsklausel ein und nehmen weitere technische Anpassungen vor.

Es wurden keine weiteren Geschäfte, Transaktionen oder Finanzberichte gemeldet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rodeheaver Carissa Lynn

(Last) (First) (Middle)
19 SOUTH SECOND STREET

(Street)
OAKLAND MD 21550

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
FIRST UNITED CORP/MD/ [ FUNC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chairman, President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/01/2025 P 38.3355(1) A $35.92 46,555.1458(2) D
Common Stock 08/04/2025 P 120.479(1) A $32.28 46,675.6248 D
Common Stock 85.041(3) I By spouse as UTMA custodian for son
Common Stock 923.2551(4) I By 401(k) plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The shares were purchased pursuant to a dividend reinvestment program offered through a brokerage account maintained by the reporting person.
2. Amount includes 128.6327 shares acquired with reinvested dividends pursuant to the First United Corporation Dividend Reinvestment and Stock Purchase Plan since the date of the last report.
3. Amount includes 0.5447 shares acquired with reinvested dividends pursuant to the First United Corporation Dividend Reinvestment and Stock Purchase Plan since the date of the last report.
4. Amount includes 6.2775 shares acquired with reinvested dividends pursuant to the First United Corporation Dividend Reinvestment and Stock Purchase Plan since the date of the last report.
/s/ Carissa L. Rodeheaver 08/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

When will Ardelyx's CFO Justin Renz leave the company?

No later than December 31, 2025, or 30 days after the new CFO’s start date, whichever comes first.

What severance benefits will the departing CFO receive?

If conditions are met, Mr. Renz receives benefits under the April 29, 2025 Change-in-Control Severance Agreement plus a 12-month option exercise window.

Why did Ardelyx amend its bylaws in August 2025?

The Second Amended & Restated Bylaws update shareholder proposal rules, quorum definitions, remove stockholder-list requirements and add a forum-selection clause.

Does the 8-K include Ardelyx’s Q2 2025 financial numbers?

No. The figures are in the press release filed as Exhibit 99.1; the 8-K only references their availability.

How do the bylaw changes affect shareholder nominations?

Shareholders must now be record owners, solicit holders of at least 67 % of voting shares, and cannot nominate more candidates than seats up for election.
First Utd Corp

NASDAQ:FUNC

FUNC Rankings

FUNC Latest News

FUNC Latest SEC Filings

FUNC Stock Data

207.96M
5.95M
8.04%
47.09%
1.6%
Banks - Regional
National Commercial Banks
Link
United States
OAKLAND